Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats

Journal of Endocrinology

Volumn 200, Issue 2, 2009, Pages 159-165

  Lu, Shou Si ^a   Yu, Yun Li ^a   Zhu, Hao Jie ^b   Liu, Xiao Dong ^a   Liu, Li ^a   Liu, Yao Wu ^a   Wang, Ping ^a   Xie, Lin ^a   Wang, Guang Ji ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; PROGLUCAGON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; ILEUM; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; L CELL; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BERBERINE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLUCAGON-LIKE PEPTIDE 1; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINES; PEPTIDE FRAGMENTS; PROGLUCAGON; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOZOCIN;

EID: 67449164807     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0419     Document Type: Article

References (33)

1. Anini Y, Hansotia T & Brubaker PL 2002 Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology 143 2420-2426.
2. Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G & Delzenne NM 2005 Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Journal of Endocrinology 185 457-465.
3. Cani PD, Hoste S, Guiot Y & Delzenne NM 2007 Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. British Journal of Nutrition 98 32-37.
4. Cheng Z, Pang T, Gu M, Gao AH, Xie CM, Li JY, Nan FJ & Li J 2006 Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochimica et Biophysica Acta 1760 1682-1689.
5. Doyle ME & Egan JM 2007 Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacology and Therapeutics 113 546-593.
6. Drucker DJ 2003 Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144 5145-5148.
7. Fehmann HC, Goke R & Goke B 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocrine Reviews 16 390-410.
8. Holst JJ & Gromada J 2004 Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. American Journal of Physiology. Endocrinology and Metabolism 287 E199-E206.
9. Holst JJ, Deacon CF, Vilsboll T, Krarup T & Madsbad S 2008 Glucagon-like peptide-1, glucose homeostasis and diabetes. Trends in Molecular Medicine 14 161-168.
10. Iritani N, Sugimoto T, Fukuda H, Komiya M & Ikeda H 1999 Oral triacylglycerols regulate plasma glucagon-like peptide-1(7-36) and insulin levels in normal and especially in obese rats. Journal of Nutrition 129 46-50.
11. Ko BS, Choi SB, Park SK, Jang JS, Kim YE & Park S 2005 Insulin sensitizing and insulinotropic action of berberine from cortidis rhizoma. Biological and Pharmaceutical Bulletin 28 1431-1437.
12. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H et al. 2004 Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine 10 1344-1351.
13. Kreymann B, Williams G, Ghatei MA & Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2 1300-1304.
14. Leng SH, Lu FE & Xu LJ 2004 Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacologica Sinica 25 496-502.
15. Liu H, Liu X, Jia L, Liu Y, Yang H, Wang G & Xie L 2008a Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes. Biochemical Pharmacology 75 1649-1658.
16. Liu L, Deng Y, Yu S, Lu S, Xie L & Liu X 2008b Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats. Die Pharmazie 63 384-388.
17. Lu T, Liang Y, Song J, Xie L, Wang GJ & Liu XD 2006 Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method. Journal of Pharmaceutical and Biomedical Analysis 40 1218-1224.
18. Meier JJ & Nauck MA 2005 Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes/Metabolism Research and Reviews 21 91-117.
19. Orskov C, Poulsen SS, Moller M & Holst JJ 1996 Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 45 832-835.
20. Pan GY, Wang GJ, Liu XD, Fawcett JP & Xie Y 2002 The involvement of P-glycoprotein in berberine absorption. Pharmacology & Toxicology 91 193-197.
21. Pan GY, Wang GJ, Sun JG, Huang ZJ, Zhao XC & Liu XD 2003 Inhibitory action of berberine on glucose absorption. Yao Xue Xue Bao 38 911-914.
22. Ritzel U, Fromme A, Ottleben M, Leonhardt U & Ramadori G 1997 Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetologica 34 18-21.
23. Schmidtler J, Schepp W, Janczewska I, Weigert N, Furlinger C, Schusdziarra V & Classen M 1991 GLP-1-(7-36) amide, -(1-37), and -(1-36) amide: potent cAMP-dependent stimuli of rat parietal cell function. American Journal of Physiology 260 940-950.
24. Tang LQ, Wei W, Chen LM & Liu S 2006 Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. Journal of Ethnopharmacology 108 109-115.
25. Turner N, Li JY, Gosby A, To SW, Cheng Z & Miyoshi H 2008 Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57 1414-1418.
26. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ & Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 69-72.
27. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM & Astrup A 2001 A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. Journal of Clinical Endocrinology and Metabolism 86 4382-4389.
28. Wang ZS, Lu FE, Chen G, Xu LJ & Zou X 2007 Effect of berberine on insulin secretion and glucokinase activity of NIT-1 cells. Yao Xue Xue Bao 42 1045-1049.
29. Yi F, Sun J, Lim GE, Fantus IG, Brubaker PL & Jin T 2008 Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells. Endocrinology 149 2341-2351.
30. Yin J, Gao Z, Liu D, Liu Z & Ye J 2007 Berberine improves glucose metabolism through induction of glycolysis. American Journal of Physiology. Endocrinology and Metabolism 8 456-459.
31. Yu S, Pang XY, Deng YX, Liu L & Liu XD 2007 A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis rhizoma in rat plasma. International Journal of Mass Spectrometry 268 30-37.
32. Zhang MF & Shen YQ 1989 Antidiarrheal and anti-inflammatory effects of berberine. Acta Pharmacologica sinica 10 174-176.
33. Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LX, Ying Y & Li DD 2008 Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biological & Pharmaceutical Bulletin 31 1169-1176.